Related Experiment Video
Updated: Apr 11, 2026

In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol
Published on: December 30, 2016
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1
Yayi Gao1, Jiayou Tang2, Weiqian Chen3
1Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, 200031, China; Clinical Immunology Center, Third Affiliated Hospital at Sun Yat-Sen University, Guangzhou, 510630, China;
Deleted in breast cancer 1 (DBC1) stabilizes the crucial FOXP3 protein in Treg cells. DBC1 deficiency enhances Treg cell function during inflammation, offering a new therapeutic target for autoimmune diseases.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Regulatory T (Treg) cells are essential for immune homeostasis.
- The molecular mechanisms governing FOXP3 complex stability and Treg cell function are not fully understood.
Purpose of the Study:
- To identify novel regulators of FOXP3 stability.
- To investigate the role of Deleted in breast cancer 1 (DBC1) in Treg cell function and inflammatory diseases.
Main Methods:
- Co-immunoprecipitation assays to confirm DBC1-FOXP3 interaction.
- Western blotting to assess FOXP3 degradation.
- Treg cell functional assays in vitro.
- In vivo studies using Dbc1-deficient mice to model experimental autoimmune encephalomyelitis and colitis.
Main Results:
- DBC1 physically interacts with FOXP3, forming a key component of the FOXP3 complex.
- DBC1 depletion significantly reduces FOXP3 degradation under inflammatory conditions.
- Treg cells from Dbc1-deficient mice exhibit enhanced resistance to inflammation-induced dysfunction.
- Dbc1 deficiency ameliorates disease severity and onset in mouse models of autoimmune diseases.
Conclusions:
- DBC1 is a critical regulator of FOXP3 stability, particularly during inflammation.
- The DBC1-FOXP3 interaction provides a novel mechanism for controlling Treg cell function.
- Targeting the DBC1-FOXP3 pathway presents a potential therapeutic strategy for inflammatory and autoimmune disorders.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Master Transcription Regulators
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

